ES
Evan Seigerman BMO Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
8.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $100 |
50%
upside
| 1 | +23% |
0
%
| 17 Feb ‘26 14 days ago |
|
|
|
Market Perform
Maintained
| $140 |
6%
upside
| 1 | – |
–
| 12 Feb ‘26 19 days ago |
|
|
|
Market Perform
Maintained
| $196 |
4%
upside
| 1 | -22% |
–
| 9 Feb ‘26 21 days ago |
|
|
|
Outperform
Upgraded
| $130 |
7%
upside
| 1 | +22% |
0
%
| 18 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $54 |
28%
upside
| 1 | +48% |
0
%
| 9 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $850 |
7%
upside
| 1 | +9.7% |
0
%
| 4 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $1,200 |
18%
upside
| 1 | +5.1% |
0
%
| 4 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $372 |
4%
downside
| 1 | +14% |
0
%
| 3 Dec ‘25 3 months ago |
|